PortfoliosLab logo

Avalo Therapeutics, Inc. (AVTX)

Equity · Currency in USD · Last updated Sep 3, 2022

Company Info

ISINUS05338F1084
CUSIP05338F108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$4.80
Year Range$3.00 - $32.88
EMA (50)$4.89
EMA (200)$11.55
Average Volume$58.57K
Market Capitalization$45.19M

AVTXShare Price Chart


Chart placeholderClick Calculate to get results

AVTXPerformance

The chart shows the growth of $10,000 invested in Avalo Therapeutics, Inc. in Nov 2015 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,000 for a total return of roughly -90.00%. All prices are adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%AprilMayJuneJulyAugustSeptember
-44.63%
-8.27%
AVTX (Avalo Therapeutics, Inc.)
Benchmark (^GSPC)

AVTXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M37.14%-4.08%
6M-44.11%-10.07%
YTD-76.47%-17.66%
1Y-87.65%-13.26%
5Y-11.34%9.65%
10Y-28.79%10.35%

AVTXMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-42.18%-25.71%-0.75%-43.31%-12.34%38.85%-40.00%31.94%1.05%
202119.32%6.98%-10.39%3.97%-15.92%23.86%-18.65%16.54%-29.68%7.34%-14.53%-15.00%
2020-26.72%-22.78%-18.69%-4.44%36.29%-19.50%5.00%-9.89%-7.52%-9.45%21.36%5.60%
201960.99%37.69%-18.44%-6.85%-10.29%11.48%-25.92%-19.60%1.54%4.56%9.59%42.97%
20183.44%40.79%-7.94%-13.29%11.56%4.58%2.30%8.78%-3.31%-12.21%-14.39%-7.98%
2017-4.02%-13.61%-7.52%-34.53%13.26%14.46%23.91%3.10%16.13%32.93%57.52%79.78%
2016-6.18%3.72%14.42%3.75%-39.53%-5.98%72.73%5.26%5.75%-12.06%-44.09%-57.67%
20155.00%-20.24%

AVTXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Avalo Therapeutics, Inc. Sharpe ratio is -0.86. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.86
-0.64
AVTX (Avalo Therapeutics, Inc.)
Benchmark (^GSPC)

AVTXDividend History


Avalo Therapeutics, Inc. doesn't pay dividends

AVTXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-94.46%
-18.19%
AVTX (Avalo Therapeutics, Inc.)
Benchmark (^GSPC)

AVTXWorst Drawdowns

The table below shows the maximum drawdowns of the Avalo Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Avalo Therapeutics, Inc. is 96.54%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.54%Feb 28, 2019808May 11, 2022
-91.55%Nov 25, 2016106Apr 28, 2017215Mar 7, 2018321
-60.57%Mar 18, 201655Jun 6, 2016117Nov 18, 2016172
-46.64%Mar 8, 2018204Dec 27, 201839Feb 25, 2019243
-35.56%Nov 19, 201547Feb 1, 201630Mar 16, 201677
-5.56%Nov 17, 20151Nov 17, 20151Nov 18, 20152

AVTXVolatility Chart

Current Avalo Therapeutics, Inc. volatility is 27.91%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%AprilMayJuneJulyAugustSeptember
27.91%
21.19%
AVTX (Avalo Therapeutics, Inc.)
Benchmark (^GSPC)